QSAR study of selective I1-imidazoline receptor ligands

SAR and QSAR in Environmental Research

Volumn 20, Issue 1-2, 2009, Pages 133-144

  Nikolic, K ^a   Filipic, S ^a   Agbaba, D ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Centrally acting antihypertensives; I1 R ligands; I1 receptor; QSAR

Indexed keywords

BINDING ENERGY; BLOOD PRESSURE; COMPUTATIONAL CHEMISTRY; LIGANDS; MOLECULAR GRAPHICS; MULTIPLE LINEAR REGRESSION; ORGANIC COMPOUNDS;

CENTRALLY ACTING ANTIHYPERTENSIVE; DESCRIPTORS; HETEROCYCLIC MOIETIES; I1-RECEPTOR; IMIDAZOLINE1-RECEPTOR LIGAND; IMIDAZOLINES; QUANTITATIVE STRUCTURE ACTIVITY RELATIONSHIP; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP MODELING; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP STUDIES; RECEPTOR LIGANDS;

DIPOLE MOMENT;

IMIDAZOLINE DERIVATIVE; IMIDAZOLINE I1 RECEPTORS; IMIDAZOLINE RECEPTOR;

ARTICLE; CHEMISTRY; METABOLISM; QUANTITATIVE STRUCTURE ACTIVITY RELATION; STATISTICAL MODEL;

IMIDAZOLINE RECEPTORS; IMIDAZOLINES; MODELS, STATISTICAL; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 67650921118     PISSN: 1062936X     EISSN: 1029046X     Source Type: Journal    
DOI: 10.1080/10629360902726015     Document Type: Article

References (34)

1. R.K Griffith, Burger's Medicinal Chemistry and Drug Discovery, 6th ed., Vol. VI, Wiley, New York, 2003.
2. 1-imidazoline-binding site is a functional receptor mediating vasodepression via the ventral medulla, Am. J. Physiol. 273 (1997), pp. R1572-R1579.
3. P. Ernsberger and I.H. Shen, Membrane localization and guanine nucleotide sensitivity of medullary I1-imidazoline binding sites, Neurochem. Int. 30 (1997), pp. 17-23.
4. F.M.J. Heemskerk, M. Dontenwill, H. Greney, C. Vonthron, and P. Bousquet, Evidence for the existence of imidazoline-specific binding sites in synaptosomal plasma membranes of the bovine brainstem, J. Neurochem. 71 (1998), pp. 2193-2202.
5. J.E. Piletz and K. Sletten, Nonadrenergic imidazoline binding sites on human platelets, J. Pharmacol. Exp. Ther. 267 (1993), pp. 1493-1502.
6. 1-imidazoline receptors: Definition, characterization, distribution, and transmembrane signalinga, Ann. N.Y. Acad. Sci. 763 (1995), pp. 22-42.
7. 1-imidazoline receptors to diacylglyceride accumulation in PC12 rat pheochromocytoma cells, Mol. Pharmacol. 49 (1996), pp. 668-675.
8. 1 imidazoline receptors to the cAMP pathway: Studies with a highly selective ligand, benazoline, Mol. Pharmacol. 57 (2000), pp. 1142-1151.
9. J.E. Piletz, J.C. Jones, H. Zhu, O. Bishara, and P. Ernsberger, Imidazoline receptor antisera-selected cDNA clone and mRNA distribution, Ann. N.Y. Acad. Sci. 881 (1999), pp. 1-7.
10. J.E. Piletz, T.R. Ivanov, J.D. Sharp, C.H. Chang, R.T. Pickard, P. Ernstmerger, and G. Gold, Imidazoline receptor antisera-selected (IRAS) cDNA: Cloning and characterization, DNA Cell Biol. 19 (2000), pp. 319-329.
11. J.E. Piletz, W. Deleersnijder, B.L. Roth, P. Ernsberger, H. Zhu, and D. Ziegler, IRAS splice variants, Ann. N.Y. Acad. Sci. 1009 (2003), pp. 419-426.
12. K.P. Lim and W. Hong, Human nischarin/imidazoline receptor antisera-selected protein is targeted to the endosomes by a combined action of a PX domain and a coiled-coil region, J. Biol. Chem. 279 (2004), pp. 54770-54782.
13. 1 imidazoline receptors, Mol. Pharmacol. 62 (2002), pp. 181-191.
14. 1 imidazoline receptor selective ligand with hypotensive activity, J. Med. Chem. 44 (2001), pp. 1588-1593.
15. R.D. Cramer, J.D. Bunce, D.E. Patterson, and I.E. Frank, Crossvalidation, bootstrapping, and partial least squares compared with multiple regression in conventional QSAR studies, QSAR Comb. Sci. 7 (1988), pp. 18-25.
16. a, lipophilicity, solubility, absorption, and polar surface area of some centrally acting antihypertensives, Bioorgan. Med. Chem. 14 (2006), pp. 1715-1728.
17. M. Remko, P.T. Van Duijnen, and M. Swart, Theoretical study of molecular structure, tautomerism, and geometrical isomerism of N-methyl- and N-phenyl-substituted cyclic imidazolines, oxazolines, and thiazolines, Struct. Chem. 14 (2003), pp. 271-278.
18. M. Remko, O.A. Walsh, and W.G. Richards, Theoretical study of molecular structure, tautomerism, and geometrical isomerism of moxonidine: Two-layered ONIOM calculations, J. Phys. Chem. A 105 (2001), pp. 6926-6931.
19. Marvin 4.1.13, ChemAxon, Budapest, Hungary, 2007; Software available at http://www.che-maxon.com/products.html.
20. A.D. Becke, Density-functional thermochemistry. III. The role of exact exchange, J. Chem. Phys. 98 (1993), pp. 5648-5652.
21. C. Lee, W. Yang, and R.G. Parr, Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density, Phys. Rev. B. 37 (1988), pp. 785-789.
22. M.J. Frisch, G.W. Trucks, H.B. Schlegel, G.E. Scuseria, M.A. Robb, J.R. Cheeseman, V.G. Zakrzewski, J.A. Montgomery Jr, R.E. Stratmann, J.C. Burant, S. Dapprich, J.M. Millam, A.D. Daniels, K.N. Kudin, M.C. Strain, O. Farkas, J. Tomasi, V. Barone, M. Cossi, R. Cammi, B. Mennucci, C. Pomelli, C. Adamo, S. Clifford, J. Ochterski, G.A. Petersson, P.Y. Ayala, Q. Cui, K. Morokuma, D.K. Malick, A.D. Rabuck, K. Raghavachari, J.B. Foresman, J. Cioslowski, J.V. Ortiz, A.G. Baboul, B.B. Stefanov, G. Liu, A. Liashenko, P. Piskorz, I. Komaromi, R. Gomperts, R.L. Martin, D.J. Fox, T. Keith, M.A. Al-Laham, C.Y. Peng, A. Nanayakkara, C. Gonzalez, M. Challacombe, P.M.W. Gill, B.G. Johnson, W. Chen, M.W. Wong, J.L. Andres, M. Head-Gordon, E.S. Replogle, and J.A. Pople, Gaussian 98 (Revision A.7), Gaussian, Inc., Pittsburgh PA, 1998.
23. S. Miertus, E. Scrocco, and J. Tomasi, Electrostatic interaction of a solute with a continuum. A direct utilization of ab initio molecular potentials for the prevision of solvent effects, Chem. Phys. 55 (1981), pp. 117-129.
24. R. Cammi and J. Tomasi, Remarks on the use of the apparent surface charges (ASC) methods in solvation problems: Iterative versus matrix-inversion procedures and the renormalization of the apparent charges, J. Comput. Chem. 16 (1995), pp. 1449-1458.
25. C.J. Casewit, K.S. Colwell, and A.K. Rappe, Application of a universal force field to organic molecules, J. Am. Chem. Soc. 114 (1992), pp. 10035-10046.
26. M.A. Thompson, ArgusLab 4.0, Planaria Software LLC, Seattle, WA, available at http:// www.ArgusLab.com
27. 1-imidazoline receptor in PC12 rat pheochromocytoma cells, J. Neurochem. 101 (2007), pp. 99-108.
28. National Center for Biotechnology Information Database, http://www.ncbi.nlm.nih.gov
29. XNUMBERS, Ver.4.7, March 2006, Multi Precision Floating Point Computing and Numerical Methods for EXCEL/2000 XP.
30. D.M. Allen, The relationship between variable selection and data augmentation and a method for prediction, Technometrics 16 (1974), pp. 125-127.
31. G. Byre, A. Mostad, and Ch. Rmming, Crystal and molecular structure of clonidine hydrochloride, 2-(2, 6-dichlorophenylamino)-2-imidazoline hydrochloride, Acta Chem. Scand. B 30 (1976), pp. 843-846.
32. D. Urosevic, S. Schann, J.D. Ehrhardt, P. Bousquet, and H. Greney, LNP 906, the first highaffinity photoaffinity ligand selective for I1 imidazoline receptors, Brit. J. Pharmacol. 142 (2004), pp. 609-617.
33. S. Joy, P.S. Nair, R. Hariharan, and M.R. Pillai, Detailed comparison of the protein-ligand docking efficiencies of gold, a commercial package and ArgusLab, a licensable freeware, In Silico Biology 6 (2006), pp. 601-605.
34. G. Jones, P. Willett, R.C. Glen, A.R. Leach, and R. Taylor, Development and validation of a genetic algorithm for flexible docking, J. Mol. Biol. 267 (1997), pp. 727-748.